Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech's GATCLiquid

GATC Biotech has released a new liquid biopsy offering for early-access clinical research and product development called GATCLiquid Technology Suite. Based on next-gen sequencing and GATC's proprietary analysis techniques, the suite is aimed at the detection of genomic alterations in circulating DNA for diagnostic purposes, such as identifying clinically actionable genomic alterations that influence tumor development or treatment outcomes.

GATC says it has already sequenced more than 40,000 samples from blood and plasma, the majority under diagnostic conditions.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.